Sarah E. Allison
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Escherichia coli research studies
Papers in
-
- Mitochondrial Function and Pathology 2
-
- Eicosanoids and Hypertension Pharmacology 5
- Co-authors
- Eric D. Brown (3 shared papers)Michael A. D’Elia (2 shared papers)Michael T. Murray (7 shared papers)Mariana G. Pinho (1 shared paper)Maya A. Farha (1 shared paper)Alexander A. C. Leung (1 shared paper)Gerard D. Wright (1 shared paper)Pedro M. Pereira (1 shared paper)
- Journals
- Biochemical Pharmacology (2 papers)Nursing Science Quarterly (2 papers)Journal of Biological Chemistry (2 papers)Journal of Medicinal Chemistry (1 paper)The FASEB Journal (1 paper)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
Sarah E. Allison
20 papers receiving 507 citations
Peers
Comparison fields: 5 of 92
- Molecular Medicine 104
- Endocrinology 54
- Issues, ethics and legal aspects 9
- Biochemistry 40
- Infectious Diseases 92
Countries citing papers authored by Sarah E. Allison
This map shows the geographic impact of Sarah E. Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Allison more than expected).
Fields of papers citing papers by Sarah E. Allison
This network shows the impact of papers produced by Sarah E. Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Allison. The network helps show where Sarah E. Allison may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah E. Allison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 172 | |
| 2 | 2011 | 44 | |
| 3 | 2013 | 37 | |
| 4 | 2017 | 33 | |
| 5 | 2017 | 32 | |
| 6 | 2007 | 29 | |
| 7 | 2014 | 29 | |
| 8 | 2017 | 25 | |
| 9 | 2013 | 19 | |
| 10 | 2012 | 16 | |
| 11 | 2015 | 16 | |
| 12 | 2013 | 12 | |
| 13 | 2015 | 11 | |
| 14 | 1972 | 10 | |
| 15 | 2016 | 9 | |
| 16 | 2013 | 7 | |
| 17 | 1973 | 7 | |
| 18 | 1993 | 5 | |
| 19 | 2009 | 5 | |
| 20 | 1991 | 3 |
About Sarah E. Allison
Sarah E. Allison is a scholar working on Molecular Biology, Biochemistry, Genetics, Pharmacology and Cancer Research, having authored 20 papers that have together received 521 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (5 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Estrogen and related hormone effects (2 papers), Salmonella and Campylobacter epidemiology (2 papers), Mitochondrial Function and Pathology (2 papers) and Family and Patient Care in Intensive Care Units (2 papers). The work is most often cited by research in Molecular Medicine (104 citations), Endocrinology (54 citations), Issues, ethics and legal aspects (9 citations), Biochemistry (40 citations) and Infectious Diseases (92 citations). Sarah E. Allison has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Eric D. Brown, Michael A. D’Elia, Michael T. Murray, Mariana G. Pinho, Maya A. Farha, Alexander A. C. Leung, Gerard D. Wright, Pedro M. Pereira, Linda Ejim and Yongjuan Chen. Their work appears in journals such as Biochemical Pharmacology, Nursing Science Quarterly, Journal of Biological Chemistry, Journal of Medicinal Chemistry and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.